Status:
COMPLETED
Examine the Feasibility of a Standardized Field Test for Marijuana and Alcohol Impairment: Laboratory Evaluations
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Highway Traffic Safety Administration (NHTSA)
Hartford Hospital
Conditions:
Marijuana Impairment
Alcohol Impairment
Eligibility:
All Genders
21-40 years
Phase:
EARLY_PHASE1
Brief Summary
Alcohol and Cannabis (CNB) are two of the most widely used intoxicants. The effects of driving while intoxicated on alcohol are well documented, resulting in numerous drunken driving laws and regulati...
Detailed Description
Alcohol is one of the most widely used substances. The effects of driving while intoxicated are well documented, leading to laws and regulations behind drunk driving. Marijuana is also a commonly abus...
Eligibility Criteria
Inclusion
- Must have a driver's license; recent 2 years highway driving experience
- Cannabis use for at least the past 2 years and report of getting high when smoking cannabis to avoid recruiting novice/inexperienced users.
- Reports regularly drinking and smoking (does not need to be at the same time)
- Use cannabis at least 5 times within life up to daily use, with occasional day of abstinence with no symptoms of craving or withdrawal.
Exclusion
- Pregnancy, breastfeeding, and ineffective birth control methods.
- Current severe substance use disorder (except cannabis and tobacco substance use disorders)
- history of adverse effects with cannabis use
- serious medical, neuro-ophthalmological, or neurological illness (i.e. cancer, seizure disorders, encephalopathy)
- current diagnosis of any DSM-5 psychiatric disorder
- prior diagnosis of any DSM-5 psychiatric disorder
- report of any psychotic disorder in a first-degree relative
- history of head trauma with loss of consciousness \> 30 minutes or concussion lasting 30 days.
- any medical/neurological condition that could compromise neurocognitive performance (i.e. epilepsy, multiple sclerosis, fetal alcohol syndrome)
- recovering alcoholics or anyone currently abstaining from alcohol.
Key Trial Info
Start Date :
July 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 23 2023
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04856566
Start Date
July 28 2021
End Date
August 23 2023
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hartford Hospital
Hartford, Connecticut, United States, 06106